Search
Exagen Inc
XGNAdd to Watchlist
4.540USD
-0.170-3.61%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
104.02MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Exagen Inc is 8.50, ranking 15 out of 75 in the Healthcare Providers & Services industry. The average price target is 15.00, with a high of 18.00 and a low of 12.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
8.571
Target Price
+80.45%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Exagen Inc
XGN
8
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Exagen Inc's expected revenue for the next quarter?
Exagen Inc's expected revenue is 17.81M.
What is Exagen Inc's price target?
Analysts forecast that Exagen Inc's price target is USD 15.00, with the highest forecast at USD 18.00 and the lowest forecast at USD 12.00.
How have Exagen IncXGN's recent earnings per share performed?
The market expectation was USD -0.17, while Exagen IncXGN's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.19.
What is the analyst rating for Exagen Inc?
Based on the ratings of Exagen Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.